AFP and hepatocellular carcinoma: So we wondered whether these surrogate parameters also statistically discriminated the group of homogeneous EpCAM-expressing HCC from the negative and heterogeneous expressing tumors, as described for EpCAM-expressing tumors in general by Yamashita et al. [11] Therefore, we assessed AFP serum levels prior to resection, as well as the number of satellite lesions.